uniQure N.V. (QURE)

↓ Download CSV

CIK 0001590560 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

In fiscal 2025, uniQure N.V. reported revenue of $16.10M, down 40.6% from the prior year. The company ran a net loss, with a net margin of -1236.0%. It held $824.91M in total assets against $626.01M in total liabilities.

Key ratios (FY2025)

-1151.4%
Operating margin
-1236.0%
Net margin
-100.0%
Return on equity
-40.6%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$16.10M$27.12M$15.84M$106.48M$524.00M$37.51M$7.28M$11.28M$13.11M$25.10M
Cost of Revenue$1.69M$1.27M$65.0K$1.25M$24.98M$2.90M$1.65M$1.20M$817.0K$1.35M
Operating Income-$185.35M-$184.29M-$282.87M-$143.16M$310.62M-$125.43M-$121.14M-$88.23M-$71.34M-$71.95M
Net Income-$198.97M-$239.56M-$308.48M-$126.79M$329.59M-$125.02M-$124.20M-$83.30M-$79.26M-$73.37M
EPS (Diluted)$-3.46$-4.92$-6.47$-2.71$7.04$-2.81$-3.11
Total Assets$824.91M$556.54M$831.69M$704.96M$809.18M$340.39M$448.63M$273.91M$209.64M$190.26M
Total Liabilities$626.01M$563.29M$624.02M$228.96M$213.40M$96.49M$125.57M$94.30M$120.28M$126.63M
Shareholders' Equity$198.90M-$6.75M$207.67M$476.01M$595.78M$243.91M$323.06M$179.61M$89.36M$63.63M
Cash & Equivalents$80.24M$158.93M$241.36M$228.01M$556.26M$244.93M$377.79M$234.90M$159.37M$132.50M
Operating Cash Flow-$177.96M-$182.73M-$145.93M-$145.06M$287.96M-$134.83M-$98.68M-$76.04M-$64.27M-$72.19M
Capital Expenditures$439.0K$3.37M$7.15M$17.69M$17.44M$7.27M$5.65M$2.38M$4.46M$15.29M
Shares Outstanding62.34M48.99M47.83M46.97M46.30M44.78M43.71M37.35M31.34M25.26M